Acasti Pharma Inc. (ACST) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 54.15M |
| Enterprise Value | 37.18M |
| P/E Ratio | -3.56 |
| PEG Ratio | -0.11 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 0.58 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -1.28 |
| Fiscal Year | March 31, 2026 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -0.15 |
| Return On Equity | -0.16 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | 0 |
| Net Income | -9.49M |
| Diluted EPS | -0.47 |
| Total Cash | 16.98M |
| Total Cash/Share | 1.03 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 8.1 |
| Book Value Per Share | 3.87 |
| 52-Week Change | 59.36 |
| 52-Week High | 3.6 |
| 52-Week Low | 1.98 |
| Moving Average 50 Days | 3.05 |
| Moving Average 200 Days | 2.99 |
| Average Volume | 33,247 |
| Shares Outstanding | 10.14M |
| % Held by Institutions | 0 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:6 |
| Last Split Date | July 10, 2023 |